nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G4A—Epirubicin—bone cancer	0.676	1	CbGbCtD
Suramin—F2—knee—bone cancer	0.0173	0.147	CbGeAlD
Suramin—F2—vertebral column—bone cancer	0.00984	0.0841	CbGeAlD
Suramin—F2—leg—bone cancer	0.00947	0.0809	CbGeAlD
Suramin—F2—forelimb—bone cancer	0.0094	0.0803	CbGeAlD
Suramin—F2—hindlimb—bone cancer	0.00846	0.0722	CbGeAlD
Suramin—F2—appendage—bone cancer	0.00725	0.062	CbGeAlD
Suramin—FSHR—connective tissue—bone cancer	0.00719	0.0614	CbGeAlD
Suramin—PLA2G4A—Raltitrexed—Methotrexate—bone cancer	0.00631	1	CbGdCrCtD
Suramin—SIRT1—connective tissue—bone cancer	0.00392	0.0335	CbGeAlD
Suramin—ARSA—connective tissue—bone cancer	0.00387	0.033	CbGeAlD
Suramin—SIRT5—tendon—bone cancer	0.00325	0.0278	CbGeAlD
Suramin—P2RX4—tendon—bone cancer	0.00307	0.0262	CbGeAlD
Suramin—P2RX4—bone marrow—bone cancer	0.00298	0.0254	CbGeAlD
Suramin—P2RX4—spinal cord—bone cancer	0.00296	0.0253	CbGeAlD
Suramin—PLA2G2A—connective tissue—bone cancer	0.00274	0.0234	CbGeAlD
Suramin—SIRT1—tendon—bone cancer	0.00269	0.023	CbGeAlD
Suramin—SIRT1—bone marrow—bone cancer	0.00261	0.0223	CbGeAlD
Suramin—SIRT1—spinal cord—bone cancer	0.0026	0.0222	CbGeAlD
Suramin—ARSA—spinal cord—bone cancer	0.00256	0.0219	CbGeAlD
Suramin—RYR1—tendon—bone cancer	0.00249	0.0212	CbGeAlD
Suramin—F2—connective tissue—bone cancer	0.00207	0.0177	CbGeAlD
Suramin—PLA2G4A—connective tissue—bone cancer	0.00191	0.0163	CbGeAlD
Suramin—PLA2G2A—tendon—bone cancer	0.00189	0.0161	CbGeAlD
Suramin—F2—bone marrow—bone cancer	0.00138	0.0118	CbGeAlD
Suramin—F2—spinal cord—bone cancer	0.00137	0.0117	CbGeAlD
Suramin—PLA2G4A—tendon—bone cancer	0.00131	0.0112	CbGeAlD
Suramin—PLA2G4A—bone marrow—bone cancer	0.00127	0.0108	CbGeAlD
Suramin—PLA2G4A—spinal cord—bone cancer	0.00126	0.0108	CbGeAlD
Suramin—SIRT1—Androgen receptor signaling pathway—RB1—bone cancer	0.000987	0.00493	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000981	0.0049	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000948	0.00474	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class III—TP53—bone cancer	0.000935	0.00467	CbGpPWpGaD
Suramin—SIRT1—Regulation of retinoblastoma protein—JUN—bone cancer	0.000929	0.00464	CbGpPWpGaD
Suramin—SIRT1—p73 transcription factor network—MDM2—bone cancer	0.000926	0.00463	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—GNA11—bone cancer	0.000902	0.00451	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—EZH2—bone cancer	0.000843	0.00421	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—MDM2—bone cancer	0.000842	0.00421	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—TUBB4B—bone cancer	0.00084	0.0042	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000831	0.00415	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000819	0.00409	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—SMO—bone cancer	0.000797	0.00398	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—SMO—bone cancer	0.000769	0.00384	CbGpPWpGaD
Suramin—F2—IL1 and megakaryotyces in obesity—MMP9—bone cancer	0.000752	0.00376	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000744	0.00372	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—GRM4—bone cancer	0.000737	0.00368	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—RGS1—bone cancer	0.000737	0.00368	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—JUN—bone cancer	0.000732	0.00366	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—TUBB2A—bone cancer	0.000725	0.00362	CbGpPWpGaD
Suramin—ARSA—Metabolism—NDUFA12—bone cancer	0.000723	0.00361	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—GRM4—bone cancer	0.000712	0.00356	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—RGS1—bone cancer	0.000712	0.00356	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—GRM4—bone cancer	0.000669	0.00334	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—RGS1—bone cancer	0.000669	0.00334	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000658	0.00329	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—GSTP1—bone cancer	0.000656	0.00328	CbGpPWpGaD
Suramin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000656	0.00328	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—CDK4—bone cancer	0.000651	0.00325	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000647	0.00323	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—GRM4—bone cancer	0.000646	0.00323	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—RGS1—bone cancer	0.000646	0.00323	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—GRM1—bone cancer	0.000641	0.0032	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—GRM1—bone cancer	0.000639	0.00319	CbGpPWpGaD
Suramin—F2—Complement and Coagulation Cascades—PLAU—bone cancer	0.000618	0.00309	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—GRM1—bone cancer	0.000617	0.00308	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000616	0.00308	CbGpPWpGaD
Suramin—ARSA—Metabolism—NT5C3A—bone cancer	0.000599	0.00299	CbGpPWpGaD
Suramin—F2—Syndecan-4-mediated signaling events—MMP9—bone cancer	0.000597	0.00298	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—CDK4—bone cancer	0.000592	0.00296	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—FUS—bone cancer	0.000587	0.00293	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—GRM1—bone cancer	0.00058	0.0029	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.00058	0.0029	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—EGFR—bone cancer	0.000575	0.00288	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000573	0.00286	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—RB1—bone cancer	0.000566	0.00283	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—GRM1—bone cancer	0.00056	0.0028	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—bone cancer	0.000556	0.00278	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000551	0.00276	CbGpPWpGaD
Suramin—RYR1—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000537	0.00268	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000523	0.00261	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MOGS—bone cancer	0.000509	0.00254	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—EIF2S1—bone cancer	0.000506	0.00253	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000479	0.0024	CbGpPWpGaD
Suramin—PLA2G4A—PDGF Pathway—JUN—bone cancer	0.000479	0.0024	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000477	0.00239	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—CDK4—bone cancer	0.000476	0.00238	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NDUFA12—bone cancer	0.000466	0.00233	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—PTGS2—bone cancer	0.000465	0.00233	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000457	0.00228	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000441	0.0022	CbGpPWpGaD
Suramin—PLA2G4A—Arachidonic acid metabolism—PTGS2—bone cancer	0.000436	0.00218	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—RB1—bone cancer	0.000414	0.00207	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—GNA11—bone cancer	0.000413	0.00206	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—GNA11—bone cancer	0.000412	0.00206	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—SMO—bone cancer	0.000409	0.00204	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—MMP9—bone cancer	0.000408	0.00204	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP2—bone cancer	0.000407	0.00204	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—NR1I2—bone cancer	0.000407	0.00203	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000406	0.00203	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—GNA11—bone cancer	0.000398	0.00199	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000397	0.00199	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GRM4—bone cancer	0.000395	0.00198	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RGS1—bone cancer	0.000395	0.00198	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000395	0.00197	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—SMO—bone cancer	0.000395	0.00197	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NT5C3A—bone cancer	0.000386	0.00193	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RGS1—bone cancer	0.000382	0.00191	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GRM4—bone cancer	0.000382	0.00191	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—JUN—bone cancer	0.000381	0.00191	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000377	0.00188	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—GNA11—bone cancer	0.000374	0.00187	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—IL3—bone cancer	0.000373	0.00187	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—GRM4—bone cancer	0.000373	0.00186	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00037	0.00185	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000369	0.00185	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000368	0.00184	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000361	0.00181	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000361	0.00181	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—GNA11—bone cancer	0.000361	0.0018	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—IL3—bone cancer	0.00036	0.0018	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—MDM2—bone cancer	0.000353	0.00176	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000345	0.00172	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GRM1—bone cancer	0.000343	0.00171	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL3—bone cancer	0.000339	0.00169	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000337	0.00168	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—JUN—bone cancer	0.000335	0.00167	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000332	0.00166	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GRM1—bone cancer	0.000331	0.00165	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.00033	0.00165	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—EGFR—bone cancer	0.00033	0.00165	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000327	0.00164	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL3—bone cancer	0.000327	0.00164	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—JUN—bone cancer	0.000327	0.00163	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—GRM1—bone cancer	0.000323	0.00161	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000316	0.00158	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—JUN—bone cancer	0.000315	0.00157	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000312	0.00156	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—JUN—bone cancer	0.000307	0.00153	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP9—bone cancer	0.000306	0.00153	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—PTGS2—bone cancer	0.000303	0.00151	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—EIF2S1—bone cancer	0.000301	0.0015	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000299	0.0015	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000281	0.00141	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—TUBB4B—bone cancer	0.000279	0.00139	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—bone cancer	0.000277	0.00138	CbGpPWpGaD
Suramin—ARSA—Metabolism—ENO2—bone cancer	0.000262	0.00131	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000262	0.00131	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—EZH2—bone cancer	0.000261	0.00131	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—BRAF—bone cancer	0.000259	0.0013	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—bone cancer	0.000252	0.00126	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—EGFR—bone cancer	0.000247	0.00124	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	0.000246	0.00123	CbGpPWpGaD
Suramin—ARSA—Metabolism—DHFR—bone cancer	0.000243	0.00122	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SMO—bone cancer	0.000241	0.00121	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—TUBB2A—bone cancer	0.000241	0.0012	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SMO—bone cancer	0.000233	0.00117	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—SMO—bone cancer	0.000228	0.00114	CbGpPWpGaD
Suramin—ARSA—Metabolism—GNA11—bone cancer	0.000227	0.00114	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—bone cancer	0.000227	0.00113	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GNA11—bone cancer	0.000221	0.0011	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NDUFA12—bone cancer	0.000219	0.0011	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GNA11—bone cancer	0.000213	0.00107	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GRM4—bone cancer	0.000211	0.00105	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—RGS1—bone cancer	0.000211	0.00105	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000209	0.00104	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—MMP2—bone cancer	0.000207	0.00103	CbGpPWpGaD
Suramin—ARSA—Metabolism—CYP3A4—bone cancer	0.000206	0.00103	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ATF1—bone cancer	0.000205	0.00103	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000205	0.00103	CbGpPWpGaD
Suramin—F2—Hemostasis—SPARC—bone cancer	0.000204	0.00102	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—bone cancer	0.000202	0.00101	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL3—bone cancer	0.0002	0.001	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ATF1—bone cancer	0.000198	0.000991	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL3—bone cancer	0.000193	0.000967	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GRM4—bone cancer	0.000191	0.000956	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—RGS1—bone cancer	0.000191	0.000956	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—JUN—bone cancer	0.000189	0.000943	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SPARC—bone cancer	0.000186	0.00093	CbGpPWpGaD
Suramin—F2—Hemostasis—GNA11—bone cancer	0.000186	0.00093	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GRM1—bone cancer	0.000183	0.000913	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NT5C3A—bone cancer	0.000182	0.000908	CbGpPWpGaD
Suramin—ARSA—Metabolism—GSTP1—bone cancer	0.000176	0.000881	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—RGS1—bone cancer	0.000175	0.000874	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GRM4—bone cancer	0.000175	0.000874	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TGFBR2—bone cancer	0.000171	0.000856	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—GNA11—bone cancer	0.00017	0.000851	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ENO2—bone cancer	0.000169	0.000845	CbGpPWpGaD
Suramin—F2—Hemostasis—IL3—bone cancer	0.000169	0.000844	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—EIF2S1—bone cancer	0.000168	0.000839	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GRM1—bone cancer	0.000166	0.000829	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TGFBR2—bone cancer	0.000165	0.000827	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF1R—bone cancer	0.000161	0.000805	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—DHFR—bone cancer	0.000157	0.000784	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF1R—bone cancer	0.000156	0.000778	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000155	0.000773	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IL3—bone cancer	0.000154	0.000772	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GRM1—bone cancer	0.000152	0.000758	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000149	0.000745	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GNA11—bone cancer	0.000147	0.000732	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000141	0.000705	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000134	0.000672	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP3A4—bone cancer	0.000133	0.000664	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000132	0.000661	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GNA11—bone cancer	0.000118	0.000588	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KIT—bone cancer	0.000117	0.000584	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—SMO—bone cancer	0.000117	0.000584	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTP1—bone cancer	0.000114	0.000568	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RGS1—bone cancer	0.000113	0.000565	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRM4—bone cancer	0.000113	0.000565	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KIT—bone cancer	0.000113	0.000564	CbGpPWpGaD
Suramin—F2—Hemostasis—PLAU—bone cancer	0.000111	0.000553	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—BRAF—bone cancer	0.00011	0.000549	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—SMO—bone cancer	0.000107	0.000534	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GNA11—bone cancer	0.000107	0.000534	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—IL3—bone cancer	0.000107	0.000533	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—EGFR—bone cancer	0.000106	0.000532	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—BRAF—bone cancer	0.000106	0.00053	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000106	0.000528	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000105	0.000525	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRM4—bone cancer	0.000103	0.000516	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RGS1—bone cancer	0.000103	0.000516	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—EGFR—bone cancer	0.000103	0.000514	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PLAU—bone cancer	0.000101	0.000506	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRM1—bone cancer	9.79e-05	0.00049	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GNA11—bone cancer	9.77e-05	0.000488	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL3—bone cancer	9.69e-05	0.000484	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MDM2—bone cancer	9.2e-05	0.00046	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—bone cancer	9.13e-05	0.000456	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRM1—bone cancer	8.96e-05	0.000448	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MDM2—bone cancer	8.89e-05	0.000444	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.88e-05	0.000444	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL3—bone cancer	8.86e-05	0.000443	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—JUN—bone cancer	8e-05	0.0004	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ENO2—bone cancer	7.96e-05	0.000398	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—bone cancer	7.78e-05	0.000389	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—JUN—bone cancer	7.73e-05	0.000386	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—bone cancer	7.52e-05	0.000376	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—DHFR—bone cancer	7.39e-05	0.000369	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GNA11—bone cancer	6.9e-05	0.000345	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SMO—bone cancer	6.9e-05	0.000345	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP2—bone cancer	6.87e-05	0.000343	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SMO—bone cancer	6.31e-05	0.000315	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GNA11—bone cancer	6.31e-05	0.000315	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EGFR—bone cancer	6.29e-05	0.000314	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP3A4—bone cancer	6.26e-05	0.000313	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.23e-05	0.000311	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EGFR—bone cancer	6.07e-05	0.000304	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—bone cancer	5.89e-05	0.000294	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ATF1—bone cancer	5.87e-05	0.000293	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GNA11—bone cancer	5.77e-05	0.000289	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL3—bone cancer	5.72e-05	0.000286	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ATF1—bone cancer	5.37e-05	0.000268	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTP1—bone cancer	5.35e-05	0.000268	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—bone cancer	5.28e-05	0.000264	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL3—bone cancer	5.23e-05	0.000262	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—bone cancer	5.1e-05	0.000255	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TGFBR2—bone cancer	4.89e-05	0.000245	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1R—bone cancer	4.6e-05	0.00023	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TGFBR2—bone cancer	4.48e-05	0.000224	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—bone cancer	4.45e-05	0.000222	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1R—bone cancer	4.21e-05	0.00021	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—bone cancer	4.07e-05	0.000203	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KIT—bone cancer	3.34e-05	0.000167	CbGpPWpGaD
Suramin—F2—Signaling Pathways—BRAF—bone cancer	3.14e-05	0.000157	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KIT—bone cancer	3.05e-05	0.000153	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EGFR—bone cancer	3.04e-05	0.000152	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—BRAF—bone cancer	2.87e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EGFR—bone cancer	2.78e-05	0.000139	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—bone cancer	2.77e-05	0.000139	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MDM2—bone cancer	2.63e-05	0.000131	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MDM2—bone cancer	2.41e-05	0.00012	CbGpPWpGaD
Suramin—F2—Signaling Pathways—JUN—bone cancer	2.29e-05	0.000114	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—bone cancer	2.22e-05	0.000111	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—JUN—bone cancer	2.09e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—bone cancer	2.03e-05	0.000102	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGFR—bone cancer	1.8e-05	8.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGFR—bone cancer	1.64e-05	8.22e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—bone cancer	1.51e-05	7.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—bone cancer	1.38e-05	6.9e-05	CbGpPWpGaD
